Intrastromal antifungal injection as a successful modality of treatment for fungal keratitis: a case series


  • Anita Maniam Department of Ophthalmology, Hospital Segamat, Johor, Malaysia
  • Goh Siew Yuen Department of Ophthalmology, Hospital Segamat, Johor, Malaysia



Amphothericin B, Fungal keratitis, Intrastromal injection, Penetrating keratoplasty


Fungal keratitis is a dreaded occurrence in the cornea and anterior segment given the difficulty in treating the disease. Hereby reporting 5 cases of fungal keratitis causes by virulent organisms such as Aspergillus versicolor, Aspergillus fumigatus, Phialophora sp, and Fusarium sp. A retrospective interventional case series of 5 fungal keratitis which were successfully treated by intrastromal antifungal injection performed by a single surgeon from March 2017 till April 2018. The fungal keratitis stromal abscess sizes range from largest of 3mm x 2mm to smallest of 1mmx 1mm, mostly located paracentral and one case was noted to have hypopyon measuring about 1mm. On the first week of treatment, patients noted to exhibit poor response to topical antifungal. Hence, intrastromal amphotericin B injection 5mcg/0.1ml about 0.1ml administered into the affected eye ranging from once to 3 times in all patients except for one patient; who is post-operative 1 year penetrating keratoplasty infected with Phialophora keratitis is given intrastromal amphotericin B injection 5mcg/0.1ml about 0.1ml for 3 times and intrastromal voriconazole injection 50mcg/0.1ml about 0.1ml for 3 times. Within next four weeks, all the 5 cases of fungal keratitis became completely quiet with healed epithelial defect and corneal scarring. In summary, the intrastromal antifungal injection can constitute a good modality for the treatment of recalcitrant cases of fungal keratitis, revealing highly potent antifungal effects as the medication is administrated directly to the site of keratitis, promises shorter recovery period, and early intrastromal antifungal injection also leads to quicker healing with good vision prognosis.


Lin HC, Chu PH, Kuo YH, Shen SC. Clinical experience in managing Fusarium solani keratitis. Int J Clin Pract. 2005 May;59(5):549-54.

Pleyer U, Grammer J, Pleyer JH, Kosmidis P, Friess D, Schmidt KH, et al. Amphotericin B-bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B. Ophthalmologe. 1995;92(4):469-75.

Thomas PA. Fungal infections of the cornea. Eye. 2003;17(8):852-62.

Xie L, Zhai H, Shi W. Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea. 2007 Feb 1;26(2):158-62.

Panda A, Vajpayee RB, Kumar TS. Critical evaluation of therapeutic keratoplasty in cases of keratomycosis. Ann Ophthalmol. 1991 Oct;23(10):373-6.

Garcia-Valenzuela E, Song CD. Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol. 2005 Dec 1;123(12):1721-3.

Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta A. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea. 2001 Oct 1;20(7):715-9.

Yilmaz S, Ture M, Maden A. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 2007 May 1;26(4):398-402.

Qu L, Li L, Xie H. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model. Ophthalmic Research. 2010;43(3):153-8.

Schwartz SD, Harrison SA, Engstrom Jr RE, Bawdon RE, Lee DA, Mondino BJ. Collagen shield delivery of amphotericin B. Am J Ophthalmol. 1990 Jun 1;109(6):701-4.

Shao Y, Yu Y, Pei CG, Tan YH, Zhou Q, Yi JL, et al. Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis. Int J Ophthalmol. 2010;3(3):257.

Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008 Jul 1;146(1):56-9.

Yee RW, Boone DE, Rinaldi MG. Antifungal agents. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye. Boston, Mass, USA: Little Brown;1996:249-267.

Qu L, Li L, Xie H. Toxicity and pharmacokinetics of intrastromal injection of amphotericin B in a rabbit model. Current Eye Res. 2014 Apr 1;39(4):340-7.

Sharma N, Agarwal P, Sinha R, et al. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: Case series. Br J Ophthalmol. 2011;95:1735-7.

Wilson LA, Sexton RR, Ahearn D. Keratochromomycosis. Arch Ophthalmol. 1966;76:811-6.

Polack FM, Siverio C, Bresky RH. Corneal chromomycosis: double infection by Phialophora verrucosa (Medlar) and Cladosporium cladosporioides (Frescenius). Ann Ophthalmol. 1976 Feb;8(2):139-44.

Ramani R, Kamath G, Sathish KR, et al. Phialophora verrucosa keratitis: successful treatment with penetrating keratoplasty. Afro-Asian J Ophthalmol. 1993;12:273-4.

Li Y, Wan Z, Li R. In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa. Antimicrobial Agents Chemotherapy. 2014 Sep 1;58(9):5609-12.




How to Cite

Maniam, A., & Yuen, G. S. (2018). Intrastromal antifungal injection as a successful modality of treatment for fungal keratitis: a case series. International Journal of Research in Medical Sciences, 7(1), 288–293.



Case Reports